Primary |
Constipation |
52.6% |
Drug Use For Unknown Indication |
10.5% |
Gastrooesophageal Reflux Disease |
10.5% |
Peptic Ulcer |
10.5% |
Abdominal Distension |
5.3% |
Blood Cholesterol Increased |
5.3% |
Product Used For Unknown Indication |
5.3% |
|
Back Pain |
10.5% |
Drug Toxicity |
10.5% |
Blood Cholesterol Increased |
5.3% |
Bowel Movement Irregularity |
5.3% |
Diarrhoea |
5.3% |
Drug Dependence |
5.3% |
Dyspnoea |
5.3% |
Feeling Abnormal |
5.3% |
Haemorrhoidal Haemorrhage |
5.3% |
Hallucination |
5.3% |
Headache |
5.3% |
Muscle Rigidity |
5.3% |
Nausea |
5.3% |
No Adverse Event |
5.3% |
Overdose |
5.3% |
Pancreatitis |
5.3% |
Ulcer Haemorrhage |
5.3% |
|
Secondary |
Drug Use For Unknown Indication |
30.1% |
Product Used For Unknown Indication |
18.2% |
Chronic Obstructive Pulmonary Disease |
5.6% |
Gastrooesophageal Reflux Disease |
4.9% |
Hypertension |
4.9% |
Hypertensive Heart Disease |
4.2% |
Osteoporosis |
4.2% |
Peptic Ulcer |
4.2% |
Blood Cholesterol Increased |
2.8% |
Constipation |
2.8% |
Cardiac Disorder |
2.1% |
Diarrhoea |
2.1% |
Dyspepsia |
2.1% |
Prophylaxis |
2.1% |
Weight Decreased |
2.1% |
Weight Loss Diet |
2.1% |
Hypercholesterolaemia |
1.4% |
Hypertensive Cardiomyopathy |
1.4% |
Pain |
1.4% |
Prostate Cancer |
1.4% |
|
Blood Cholesterol Increased |
11.1% |
Nausea |
7.4% |
No Adverse Event |
7.4% |
Photophobia |
7.4% |
Sepsis |
7.4% |
Vertebral Artery Occlusion |
7.4% |
Abdominal Discomfort |
3.7% |
Abdominal Pain Upper |
3.7% |
Agitation |
3.7% |
Brain Stem Stroke |
3.7% |
Death |
3.7% |
Dermatitis Atopic |
3.7% |
Diarrhoea |
3.7% |
Drug Abuse |
3.7% |
Drug Dose Omission |
3.7% |
Drug Ineffective |
3.7% |
Feeling Hot |
3.7% |
Flat Anterior Chamber Of Eye |
3.7% |
Myopia |
3.7% |
Renal Failure |
3.7% |
|
Concomitant |
Drug Use For Unknown Indication |
40.7% |
Product Used For Unknown Indication |
19.0% |
Pain |
5.8% |
Acute Lymphocytic Leukaemia |
4.2% |
Constipation |
3.6% |
Prophylaxis |
3.1% |
Hypertension |
2.8% |
Nausea |
2.0% |
Rheumatoid Arthritis |
2.0% |
Depression |
2.0% |
Multiple Myeloma |
1.9% |
Non-small Cell Lung Cancer |
1.9% |
Gastrooesophageal Reflux Disease |
1.8% |
Dyspepsia |
1.8% |
Crohn's Disease |
1.4% |
Anxiety |
1.3% |
Cough |
1.2% |
Insomnia |
1.2% |
Diffuse Large B-cell Lymphoma |
1.2% |
Vitamin Supplementation |
1.2% |
|
Vomiting |
17.2% |
Weight Decreased |
11.3% |
White Blood Cell Count Decreased |
5.9% |
Pneumonia |
5.4% |
Sepsis |
5.4% |
Thrombocytopenia |
5.4% |
Vocal Cord Paralysis |
5.0% |
Nausea |
4.6% |
Syncope |
4.6% |
Tumour Lysis Syndrome |
4.2% |
Malaise |
3.8% |
Pain |
3.8% |
Constipation |
3.3% |
Granulocytopenia |
3.3% |
Anxiety |
2.9% |
Drug Dose Omission |
2.9% |
Headache |
2.9% |
Myocardial Infarction |
2.9% |
Alanine Aminotransferase Increased |
2.5% |
Cholecystitis Chronic |
2.5% |
|